Perceptions, Behaviors and Factors Affecting Benzodiazepine Use among Patients Receiving Methadone Maintenance Therapy in a Northern Hospital

Main Article Content

์Nannaphat Rungsiwaroj
Puckwipa Suwannaprom
Siritree Suttajit

Abstract

Objective: To study perceptions, behaviors and factors leading to the use of benzodiazepines (BZDs) among patients receiving methadone maintenance therapy in a northern hospital. Methods: This study was conducted by in-depth interviews with 13 informants treated with methadone in a Northern hospital who were purposively selected from those receiving methadone maintenance therapy with at least one BZDs or had behaviors or with the history of solicitation of BZDs from healthcare professionals. Snowball sampling was also employed to identify informants seeking BZDs from sources outsides the hospital. Results: Perceptions of BZDs among users of this drugs varied according to their purpose of use. Those using it to treat illnesses recognized BZDs as sleeping pills, stress relievers, and anti-anxiety drugs. It was mainly used by ingestion. While those using it for recreation in the form of narcotics recognized the drug as intoxicating drugs or sedatives, and took the drug by ingestion or mixing with methadone for injecting into the body. Factors leading drug use were mental and physical health problems, family problems stemming from misunderstanding of methadone treatment, having friends who were users of this drugs, stressful occupation, living in an urban community with easy access to the drug, the restriction of the amount of drug dispensed from public hospitals, and the BZDs controlling law. Conclusion: Methadone users had different views of BZDs. When not receiving the expected treatment for illnesses from the hospital, they searched for self-treatments from other sources. Not only should healthcare professionals treat physical ailments, but they should also have a better understanding the views of methadone users, and should identify factors leading to BZDs use.

Article Details

Section
Research Articles

References

Kummuang S, Panthuan S, Kongsitrattanatrakul T, Dokshan P. Public policy on drug prevention and suppression of Thailand. Dhammathas Academic Journal 2022; 22: 409-20.

Princess Mother National Institute on Drug Abuse Treatment. Harm reduction services guide for providers. Bangkok: Chulapress; 2018.

Princess Mother National Institute on Drug Abuse Treatment. Methadone maintenance treatment. Bangkok: Chulapress; 2010.

National Institute on Drug Abuse. Benzodiazepines and opioids [online]. 2019 [cited June 10, 2023]. Available from: www.nida.nih.gov/research-topics/opi oids/benzodiazepines-opioids.

Mathers BM, Degenhardt L, Phillips B. Global epide-miology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372: 1733-45.

World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: World Health Organiza- tion; 2009.

Griffin CE, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J 2013; 13: 214–23.

Aumpon V. Study of measures resolving the abuse of psychotropic substances consumption on benzodia-zepines group. FDA Journal 2013; 20: 21-9.

Sun EC, Dixit A, Humphreys K. Association between concurrent use of prescription opioids and benzodia- zepines and overdose: retrospective analysis. BMJ 2017; 356: 760. doi.org/10.1136/bmj.j760.

Karahong K, Suwannaprom P, Ruanta Y, Awiphan R. Meaning and perceptions toward benzodiazepine use behavior in the view of people in rural community. Thai Journal of Pharmacy Practice 2018; 10: 264-75.

Kleinman A. Concepts and a model for the compari son of medical systems as cultural systems. Soc Sci Med 1978; 12: 85-93.

Sallis JF, Owen N, Fisher EB. Ecological models of health behavior. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education: Theory, research and practice. 4th ed. San Francisco: Jossey-Bass; 2008. p 465-85.

Kevin WC, Christine CB, Darlene PF, Christopher DA, Eric W, Devang G. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry 2011; 11: 90. doi: 10.1186/1471-244 X-11-90.

Kim J, Jesus OD. Medication routes of administra- tion [online]. 2022 [cited Feb 14, 2023]. Available from: www.ncbi.nlm.nih.gov/books/NBK568677.

Ashton H. The diagnosis and management of benzo- diazepine dependence. Curr Opin Psychiatry 2005; 18: 249-55.

Weschules DJ, Bain KT, Richeimer S. Actual and potential drug interactions associated with methadone. Pain Med 2008; 9: 315-44.

Stein MD, Kanabar M, Anderson BJ, Lembke A, Bailey GL. Reasons for benzodiazepine use among persons seeking opioid detoxification. J Subst Abuse Treat 2016; 68: 57-61.

Laoniramai P, Laosee OC, Somrongthong R, Wongchalee S, Sitthi-Amorn C. Factors affecting the experiences of drug use by adolescents in a Bangkok slum. Southeast Asian J Trop Med Public Health. 2005; 36: 1014-9.

Bush DM, Lipari RN. Substance use and substance use disorder by Industry [online]. 2015 [cited Feb 20, 2023]. Available from: www.samhsa.gov/data/sites/ default/files/report_1959/ShortReport-1959.

Sriprasert D. Medical dominance and the doctor-patient relationship. Thammasat Journal 2018; 37: 78-95.

The Act on Promulgation of Narcotics Code. Royal Gazette No. 138, Part 73A (Nov 8, 2021).